Angmo D, Mahalingam K, Gowtham L, Elancheliyan P, Velpandian T, Sihota R, Dada T. Analysis of the systemic exposure of Mitomycin C used in glaucoma filtering surgery among women in the reproductive age group.
Curr Eye Res 2023:1-2. [PMID:
36892194 DOI:
10.1080/02713683.2023.2189636]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/10/2023]
Abstract
PURPOSE
Systemic absorbtion of topically applied mitomycin C (MMC) during trabeculectomy needs to be evaluated to look for any systemic toxicity, which might be a major concern in certain conditions like pregnancy.
METHODS
After obtaining ethical committee clearance, female patients in the reproductive age group undergoing trabeculectomy with MMC were included. Pregnant/lactating patients, patients with any systemic illness were excluded.During trabeculectomy, 0.02% MMC was applied subconjunctivally for 2 minutes and then washed. Blood samples were withdrawn at 1hr, 2hr, 4hr, 8hr, 12hr, and 24hrs after the surgery and analyzed of MMC levels using Liquid chromatography-tandem mass spectroscopy (LCMS-MS).
RESULTS
The mean age of the participants was 29 ± 12 years. MMC was not detected in any of the plasma samples analyzed as it was less than the detection limit (<1.56ng/mL) of the employed LC-MS/MS assay.
CONCLUSION
It can be deduced that the systemic absorption of MMC is negligible or the plasma concentration is less than 1.56ng/ml (1000 times less than the concentration where systemic toxicity was not observed).
Collapse